亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台,協助業界發掘知識產權貿易商機,並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權,或是製造商需要購買技術以提高操作效能,又或是知識產權配套服務供應商,你將會從本網站發掘到有用的知識產權貿易資訊。

A Cell-Based Seeding Assay for Huntingtin Aggregation

技術優勢
SpecificSensitiveHigh throughputCorrelates with disease progressionCompatible with biological samples
技術應用
Huntington's Disease diagnosis Drug discoveryClinical trial biomarker
詳細技術說明
A novel high throughput cell-based seeding assay was developed to detect mutant HTT proteins. This approach utilizes a transgenic cell line that expresses a form of mHTT, which is linked to a green fluorescent protein (GFP), making any aggregates easily quantifiable. The cell line has a very low baseline level of aggregates. However, it can be highly specifically induced to form aggregates with even very small aggregate seeds are introduced from HD patients or mouse samples. The readout correlates well with the amount of seeds added and with the disease stage of the HD patients.
*Abstract
UCLA researchers from the Department of Psychiatry has created a novel cell-based seeding assay for sensitive, specific and high throughput detection of mutant Huntingtin proteins in biological samples.
*Principal Investigation

Name: Chung-Ying Lee

Department:


Name: Nan Wang

Department:


Name: Xiangdong Yang

Department:

其他

Background

Huntington’s disease (HD) is a lethal genetic disorder that is caused by mutatations in thehuntingtin protein (mHTT). Genetic errors cause an elongated repeat motif to result in a polyglutamine (polyQ) stretch in the expressed protein, causing it to form aggregates. These aggregates accumulate in the nerve cells eventually lead to their breakdown, incurring debilitating effects. Current molecular methods of diagnosing HD include direct detection, in vitro aggregation detection and cell based detection. Direct detection of HTT uses antibodies, which can only detect a subset of HTT in soluble, monomer forms. In vitro aggregation detection lacks sensitivity. Other existing cell based detection approaches are prone to false positives and are labor intensive.


Additional Technologies by these Inventors


Tech ID/UC Case

29135/2018-193-0


Related Cases

2018-193-0

國家/地區
美國

欲了解更多信息,請點擊 這裡
移動設備